Skip to main content
. 2021 Jan 11;7:501104. doi: 10.3389/fmed.2020.501104

Table 7.

Combined effect estimates and heterogeneity for actigraphy outcomes between dementia and control samples.

Actigraphy measure Included studies, no. Dementia subjects, no. Healthy subjects, no. Pooled mean difference, random-effects model (95% CI) Q I2 (95% CI)
IS 10 298 180 −0.47 (−0.81, −0.14) 24.86 (9 df)§ 64 (29, 82)
IV 9 245 171 0.46 (0.27, 0.65) 6.61 (8 df) 0 (0, 65)
RA 9 237 152 −0.53 (−0.76, −0.30) 15.39 (8 df) 48 (0, 76)
L5 8 184 103 0.38 (0.15, 0.61)§ 11.21 (7 df) 38 (0, 72)
M10 8 184 103 −0.61 (−1.16, −0.06)§ 30.32 (7 df) 77 (54, 88)
TST 7 291 212 0.46 (−0.21, 1.12) 30.31 (6 df) 80 (60, 90)
SE 8 193 171 −0.52 (−0.89, −0.16)§ 15.44 (7 df)§ 55 (0, 80)
Amplitude 7 174 93 −1.22 (−1.94, −0.50) 36.34 (6 df) 83 (67, 92)
Daytime Activity 7 210 136 −1.60 (−2.66, −0.55)§ 81.82 (6 df) 93 (87, 96)

df, degrees of freedom; IS, interdaily stability; IV, intradaily variability; I2, percentage of variation across studies due to heterogeneity; L5, activity of least active 5 h; M10, activity of most active 10 h; No., number; Q, Cochran's Q weighted sum of squares of effect size estimates subtracted by their mean; RA, relative amplitude; SE, sleep efficiency; TST, total sleep time.

p < 0.0001.

p < 0.001.

§

p < 0.05.